University of Alabama at Birmingham, School of Public Health, Birmingham, Alabama.
University of Alabama at Birmingham, School of Public Health, Birmingham, Alabama.
J Adolesc Health. 2022 Dec;71(6):673-678. doi: 10.1016/j.jadohealth.2022.07.015. Epub 2022 Oct 5.
The first vaccine against SARS-CoV-2 (COVID-19) for adolescents 16 years and older in the United States received Emergency Use Authorization in December 2020. Soon after its approval, parents expressed concerns about vaccine safety for adolescents. Similar concerns about vaccine safety partially explain suboptimal human papillomavirus (HPV) vaccine uptake. This qualitative study explores similarities and differences in parents' attitudes about these two vaccines.
Parents were recruited through social media and at health centers in Alabama. Semi-structured interviews with parents of adolescents aged 9-17 years were conducted before and after Alabama expanded age eligibility to those 16 and older. Topics included knowledge about HPV and COVID-19 vaccines, and parents' intentions to have children vaccinated. Interviews were analyzed using thematic analysis.
From March 11, 2021 to April 24, 2021, 21 in-depth interviews were conducted. Parents discussed the importance of HPV and COVID-19 vaccines for protecting their children's health but differences between the two related to community protection. Parents were concerned about vaccine safety but media coverage about the COVID-19 vaccine led to more favorable attitudes about the benefits of vaccination, which was not observed for HPV vaccines. Instead for HPV vaccination, parents wanted their healthcare providers' opinions about the vaccine before making a vaccination decision.
Parents had similar concerns about HPV and COVID-19 vaccines. Although provider recommendations can improve vaccine uptake, local news reports were seen to have a positive impact on COVID-19 vaccine acceptance in lieu of provider recommendation. Disseminating information online could be beneficial to promote HPV and COVID-19 vaccines.
美国针对 16 岁及以上青少年的首款 SARS-CoV-2（COVID-19）疫苗于 2020 年 12 月获得紧急使用授权。在获得批准后不久，家长们对青少年疫苗的安全性表示担忧。对疫苗安全性的类似担忧部分解释了 HPV 疫苗接种率不理想的原因。这项定性研究探讨了家长对这两种疫苗的态度的相似之处和不同之处。
通过社交媒体和阿拉巴马州的医疗中心招募家长。在阿拉巴马州将接种年龄扩大到 16 岁及以上之前和之后，对 9-17 岁青少年的家长进行了半结构化访谈。主题包括 HPV 和 COVID-19 疫苗的知识，以及家长让孩子接种疫苗的意愿。使用主题分析对访谈进行分析。
从 2021 年 3 月 11 日至 2021 年 4 月 24 日，进行了 21 次深入访谈。家长们讨论了 HPV 和 COVID-19 疫苗对保护孩子健康的重要性，但两者之间的区别在于社区保护。家长们对疫苗的安全性表示担忧，但媒体对 COVID-19 疫苗的报道导致了对疫苗接种益处的更有利态度，而这在 HPV 疫苗中并未观察到。相反，对于 HPV 疫苗接种，家长希望在做出接种决定之前听取医疗服务提供者对疫苗的意见。
家长对 HPV 和 COVID-19 疫苗有类似的担忧。虽然提供者的建议可以提高疫苗接种率，但地方新闻报道被视为对 COVID-19 疫苗接种接受度产生积极影响，而不是提供者的建议。在网上传播信息可能有助于促进 HPV 和 COVID-19 疫苗的推广。
